{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:35:54Z","timestamp":1784687754977,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.bbi.2010.04.003","type":"journal-article","created":{"date-parts":[[2010,4,11]],"date-time":"2010-04-11T04:33:50Z","timestamp":1270960430000},"page":"975-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11\u03b2-hydroxysteroid dehydrogenases in multiple sclerosis: Implications for lesion pathogenesis"],"prefix":"10.1016","volume":"24","author":[{"given":"Claudia","family":"Heidbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian F.M.","family":"H\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Buttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Ossadnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig M.","family":"Strik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evert","family":"Verbraak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"van Meurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Krockenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Mittelbronn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Laman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wischhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2010.04.003_bib1","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1096\/fj.07-8140com","article-title":"Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity","volume":"21","author":"Alikhani-Koupaei","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2010.04.003_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0022-510X(93)90030-3","article-title":"Neurosteroids in cerebrospinal fluid in neurologic disorders","volume":"120","author":"Azuma","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2010.04.003_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2010.04.003_bib4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","article-title":"Macrophage deactivation by interleukin 10","volume":"174","author":"Bogdan","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2010.04.003_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/brain\/awh707","article-title":"Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis","volume":"129","author":"Boven","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2010.04.003_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0197-4580(02)00048-9","article-title":"Oxidative stress-mediated DHEA formation in Alzheimer\u2019s disease pathology","volume":"24","author":"Brown","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2010.04.003_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2005.11.036","article-title":"11Beta-hydroxysteroid dehydrogenase type 1 \u2013 a role in inflammation?","volume":"248","author":"Chapman","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbi.2010.04.003_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/01.wnl.0000341934.12142.74","article-title":"Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS","volume":"72","author":"Cohen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2010.04.003_bib9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2010.04.003_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(10)70007-7","article-title":"Combination therapy in multiple sclerosis","volume":"9","author":"Conway","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2010.04.003_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/eje.0.1460231","article-title":"Cortisol-binding globulin is important in the interpretation of dynamic tests of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"146","author":"Dhillo","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbi.2010.04.003_bib12","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.4049\/jimmunol.167.12.7094","article-title":"Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL\/J mice","volume":"167","author":"Du","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2010.04.003_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1191\/1352458502ms797oa","article-title":"Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis","volume":"8","author":"Erkut","year":"2002","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2010.04.003_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archneur.55.1.66","article-title":"Mood disorders and dysfunction of the hypothalamic\u2013pituitary\u2013adrenal axis in multiple sclerosis: association with cerebral inflammation","volume":"55","author":"Fassbender","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbi.2010.04.003_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(08)70191-1","article-title":"Grey matter pathology in multiple sclerosis","volume":"7","author":"Geurts","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2010.04.003_bib16","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.4049\/jimmunol.176.12.7605","article-title":"Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes","volume":"176","author":"Gilmour","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2010.04.003_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/1073858404263494","article-title":"Glucocorticoids: protectors of the brain during innate immune responses","volume":"10","author":"Glezer","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbi.2010.04.003_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jneuroim.2005.04.014","article-title":"Hypothalamo\u2013pituitary\u2013adrenal axis activity predicts disease progression in multiple sclerosis","volume":"165","author":"Gold","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2010.04.003_bib19","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1210\/en.2005-1625","article-title":"Expression and functional state of the corticosteroid receptors and 11 beta-hydroxysteroid dehydrogenase type 2 in Schwann cells","volume":"147","author":"Groyer","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbi.2010.04.003_bib20","first-page":"3951","article-title":"Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age","volume":"81","author":"Guazzo","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbi.2010.04.003_bib21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/eph8702411","article-title":"Neuroendocrine function and chronic inflammatory stress","volume":"87","author":"Harbuz","year":"2002","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.bbi.2010.04.003_bib21a","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.shk.0000081408.57952.22","article-title":"The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model","volume":"20","author":"Hildebrand","year":"2003","journal-title":"Shock"},{"key":"10.1016\/j.bbi.2010.04.003_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jnnp.2007.127332","article-title":"Survival and cause of death in multiple sclerosis: a prospective population-based study","volume":"79","author":"Hirst","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbi.2010.04.003_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.bbi.2010.04.003_bib24","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/cc5729","article-title":"Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis","volume":"11","author":"Holub","year":"2007","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbi.2010.04.003_bib25","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1210\/jc.2003-030646","article-title":"Neurosteroids: cerebrospinal fluid levels for Alzheimer\u2019s disease and vascular dementia diagnostics","volume":"88","author":"Kim","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbi.2010.04.003_bib25a","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0736-5748(99)00067-2","article-title":"Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor alpha and interleukin-6 in astrocytes","volume":"17","author":"Kipper-Galperin","year":"1999","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbi.2010.04.003_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000054505","article-title":"Dehydroepiandrosterone response to the adrenocorticotropin test and the combined dexamethasone and corticotropin-releasing hormone test in patients with multiple sclerosis","volume":"70","author":"K\u00fcmpfel","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bbi.2010.04.003_bib27","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2010.04.003_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbi.2010.04.003_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1034\/j.1600-0404.2002.01155.x","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment","volume":"105","author":"Limone","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbi.2010.04.003_bib30","first-page":"848","article-title":"Multiple sclerosis is associated with alterations in hypothalamic\u2013pituitary\u2013adrenal axis function","volume":"79","author":"Michelson","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbi.2010.04.003_bib31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s00125-004-1407-6","article-title":"11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle","volume":"47","author":"Nair","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbi.2010.04.003_bib32","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.50.6.1833","article-title":"Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study","volume":"50","author":"Oliveri","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2010.04.003_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuroscience.2006.11.038","article-title":"Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain","volume":"145","author":"Pelletier","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2010.04.003_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2010.04.003_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1210\/jcem-58-1-6","article-title":"Protein binding of cortisol in human cerebrospinal fluid","volume":"58","author":"Predine","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbi.2010.04.003_bib36","series-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2009"},{"key":"10.1016\/j.bbi.2010.04.003_bib37","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.21091","article-title":"Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?","volume":"52","author":"Schmidt","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbi.2010.04.003_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ana.10187","article-title":"Activity of the hypothalamic\u2013pituitary\u2013adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume","volume":"51","author":"Schumann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2010.04.003_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/frne.1996.0143","article-title":"11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?","volume":"18","author":"Seckl","year":"1997","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.bbi.2010.04.003_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jocn.2004.12.008","article-title":"Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone","volume":"13","author":"Shimojima","year":"2006","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbi.2010.04.003_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(09)70085-7","article-title":"NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial","volume":"8","author":"Sorensen","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2010.04.003_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1191\/135248505ms1322oa","article-title":"Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone","volume":"12","author":"Tellez","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2010.04.003_bib43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1212\/WNL.53.4.772","article-title":"Dysregulation of the hypothalamo\u2013pituitary\u2013adrenal axis is related to the clinical course of MS","volume":"53","author":"Then Bergh","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2010.04.003_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4049\/jimmunol.167.1.30","article-title":"11 Beta-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages","volume":"167","author":"Thieringer","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2010.04.003_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2007.03.007","article-title":"Glucocorticoids in the control of neuroinflammation","volume":"275","author":"Tischner","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbi.2010.04.003_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2007.08.045","article-title":"Neurosteroids reduce inflammation after TBI through CD55 induction","volume":"425","author":"VanLandingham","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"Pt. 6","key":"10.1016\/j.bbi.2010.04.003_bib47","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/120.6.1067","article-title":"The neuroendocrine axis in patients with multiple sclerosis","volume":"120","author":"Wei","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2010.04.003_bib48","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/01.wnl.0000336918.32695.6b","article-title":"Impaired hypothalamic\u2013pituitary\u2013adrenal axis activity in patients with multiple sclerosis","volume":"71","author":"Ysrraelit","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2010.04.003_bib49","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4049\/jimmunol.174.2.879","article-title":"The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities","volume":"174","author":"Zhang","year":"2005","journal-title":"J. Immunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159110000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159110000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:24:23Z","timestamp":1760167463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159110000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0889159110000929"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2010.04.003","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced cortisol levels in cerebrospinal fluid and differential distribution of 11\u03b2-hydroxysteroid dehydrogenases in multiple sclerosis: Implications for lesion pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2010.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}